MALVERN, PA — Ocugen, Inc., (NASDAQ: OCGN), a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases, announced the appointment of Jessica Crespo, CPA, to the role of Controller, effective October 23, 2019.
Sanjay Subramanian, Chief Financial Officer, remarked, “We are thrilled to have Jess join our team at Ocugen. We believe her extensive experience leading the accounting function at several public life science companies will be a tremendous addition to our organization.”
Ms. Crespo commented, “I am excited to join Ocugen and expand upon the financial infrastructure that has been built. Ocugen’s diverse pipeline of ophthalmology programs are exciting and I look forward to working with the team to advance the Phase 3 ocular GVHD program and prepare the modifier gene therapy platform to enter the clinic.”
Ms. Crespo brings more than 20 years’ experience in corporate and technical accounting, financial reporting, and internal controls within a ‘Big 4’ public accounting firm and at rapidly growing public life science companies. She most recently served as Director, Accounting/Finance at Aerie Pharmaceuticals and supported the organization through two product launches. Prior to her service at Aerie, she held positions at Aralez Pharmaceuticals and Cubist Pharmaceuticals. She began her career at Ernst & Young LLP. Ms. Crespo holds a Bachelor of Science in Accounting from Boston College and is a Certified Public Accountant.
Source: Ocugen, Inc., 5 Great Valley Parkway, Suite 160, Malvern PA 19355
Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.